UniDoc Health Corp(UDOCF)
$0.04+0.01 (+21.21%)
UDOCF
UniDoc Health Corp financials statements
$0.04
At close:+0.01 (+21.21%)
UniDoc Health Corp (UDOCF) Ratios
62 Followers
UniDoc Health Corp Ratios
UDOCF's free cash flow for Q4 2026 was C$-353.39K. For the 2026 fiscal year, UDOCF's free cash flow was increased by C$2.06K and operating cash flow was C$-355.45K. See a summary of the company’s cash flow.
| Ratios | Jun 26 | Jun 25 | Jun 24 | Jun 22 | Mar 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 0.33 | 0.99 | 0.21 | 1.50 | 0.68 |
| Quick Ratio | 0.33 | 0.99 | 0.19 | 1.50 | 0.68 |
| Cash Ratio | 0.11 | 0.61 | 0.17 | 1.28 | 0.66 |
| Solvency Ratio | -1.17 | -2.69 | -0.92 | -4.14 | -0.07 |
| Operating Cash Flow Ratio | -0.96 | -3.58 | -0.24 | -3.58 | 0.04 |
| Short-Term Operating Cash Flow Coverage | -88.36 | -523.03 | -16.00 | -96.41 | 0.09 |
| Net Current Asset Value | C$ -1.81M | C$ -194.45K | C$ -1.90M | C$ 281.70K | C$ -136.73K |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.02 | 0.02 | 0.14 | 0.07 | 0.69 |
| Debt-to-Equity Ratio | -0.03 | 0.10 | -0.04 | 0.17 | -1.46 |
| Debt-to-Capital Ratio | -0.03 | 0.09 | -0.04 | 0.15 | 3.16 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | -0.01 | 0.00 | 0.00 |
| Financial Leverage Ratio | -1.49 | 4.37 | -0.28 | 2.58 | -2.11 |
| Debt Service Coverage Ratio | -89.87 | -52.52 | -49.98 | -112.66 | -1.19 |
| Interest Coverage Ratio | -500.19 | -58.70 | -253.68 | -1695.63 | 0.00 |
| Debt to Market Cap | 0.00 | 0.00 | 0.00 | 0.06 | 0.10 |
| Interest Debt Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Debt to EBITDA | 0.08 | 0.20 | 0.15 | 0.26 | 0.34 |
| Profitability Margins | |||||
| Gross Profit Margin | 7.02% | 0.00% | 0.00% | 0.00% | 0.00% |
| EBIT Margin | -331.94% | 0.00% | 0.00% | 0.00% | 0.00% |
| EBITDA Margin | -312.50% | 0.00% | 0.00% | 0.00% | 0.00% |
| Operating Profit Margin | -331.94% | 0.00% | 0.00% | 0.00% | 0.00% |
| Pretax Profit Margin | -344.74% | 0.00% | 0.00% | 0.00% | 0.00% |
| Net Profit Margin | -344.74% | 0.00% | 0.00% | 0.00% | 0.00% |
| Continuous Operations Profit Margin | -344.74% | 0.00% | 0.00% | 0.00% | 0.00% |
| Net Income Per EBT | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
| EBT Per EBIT | 103.86% | 104.65% | 102.69% | 100.07% | 100.00% |
| Return on Assets (ROA) | -207.61% | -208.69% | -437.04% | -255.11% | -82.29% |
| Return on Equity (ROE) | 310.08% | -912.45% | 121.28% | -658.58% | 173.57% |
| Return on Capital Employed (ROCE) | 362.24% | -690.18% | 118.96% | -587.88% | 173.57% |
| Return on Invested Capital (ROIC) | 373.71% | -657.08% | 123.04% | -535.95% | -375.10% |
| Return on Tangible Assets | -359.35% | -288.13% | -437.04% | -255.11% | -82.29% |
| Earnings Yield | -34.87% | -32.42% | -10.20% | -758.18% | -11.85% |
| Efficiency Ratios | |||||
| Receivables Turnover | 3.50 | 0.00 | 0.00 | 0.00 | 0.00 |
| Payables Turnover | 0.46 | 0.03 | 0.04 | 0.04 | 0.00 |
| Inventory Turnover | 0.00 | 0.00 | 2.11 | 0.00 | 0.00 |
| Fixed Asset Turnover | 8.46 | 0.00 | 0.00 | 0.00 | 0.00 |
| Asset Turnover | 0.60 | 0.00 | 0.00 | 0.00 | 0.00 |
| Working Capital Turnover Ratio | -1.14 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | -683.54 | -13125.91 | -8744.05 | -8607.73 | 0.00 |
| Days of Sales Outstanding | 104.24 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 172.95 | 0.00 | 0.00 |
| Days of Payables Outstanding | 787.77 | 13125.91 | 8917.00 | 8607.73 | 0.00 |
| Operating Cycle | 104.24 | 0.00 | 172.95 | 0.00 | 0.00 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.03 | -0.13 | -0.01 | -0.11 | 0.00 |
| Free Cash Flow Per Share | -0.03 | -0.14 | -0.01 | -0.11 | 0.00 |
| Dividend Paid and CapEx Coverage Ratio | -32.69 | -28.70 | 0.00 | -46.57 | 5751.00 |
| Capital Expenditure Coverage Ratio | -32.69 | -28.70 | 0.00 | -46.57 | 5751.00 |
| Operating Cash Flow Coverage Ratio | -88.36 | -107.71 | -7.48 | -30.10 | 0.09 |
| Operating Cash Flow to Sales Ratio | -2.49 | 0.00 | 0.00 | 0.00 | 0.00 |
| Free Cash Flow Yield | -25.92% | -40.94% | -2.53% | -614.98% | 0.86% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -2.87 | -3.05 | -9.80 | -0.13 | -8.44 |
| Price-to-Sales (P/S) Ratio | 9.89 | 0.00 | 0.00 | 0.00 | 0.00 |
| Price-to-Book (P/B) Ratio | -8.89 | 28.14 | -11.89 | 0.87 | -14.65 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -3.86 | -2.44 | -39.56 | -0.16 | 116.11 |
| Price-to-Operating Cash Flow Ratio | -3.98 | -2.53 | -39.56 | -0.17 | 116.11 |
| Price-to-Earnings Growth (PEG) Ratio | 0.05 | -0.02 | 0.35 | -0.00 | 0.00 |
| Enterprise Value Multiple | -3.08 | -2.96 | -10.00 | 0.13 | -8.10 |
| Enterprise Value | 9.02M | 17.52M | 21.83M | -378.81K | 1.92M |
| EV to EBITDA | -3.08 | -2.96 | -10.00 | 0.13 | -8.10 |
| EV to Sales | 9.62 | 0.00 | 0.00 | 0.00 | 0.00 |
| EV to Free Cash Flow | -3.76 | -2.29 | -38.98 | 0.16 | 111.37 |
| EV to Operating Cash Flow | -3.87 | -2.37 | -38.98 | 0.16 | 111.37 |
| Tangible Book Value Per Share | -0.02 | -0.00 | -0.04 | 0.02 | -0.00 |
| Shareholders’ Equity Per Share | -0.01 | 0.01 | -0.04 | 0.02 | -0.00 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Revenue Per Share | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income Per Share | -0.04 | -0.11 | -0.04 | -0.14 | -0.00 |
| Tax Burden | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Interest Burden | 1.04 | 1.02 | 1.00 | 1.00 | 1.00 |
| Research & Development to Revenue | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 3.38 | 0.00 | 0.00 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 0.72 | 1.22 | 0.25 | 0.79 | -0.07 |
Currency in CAD
